A Rothe, H Schulz, T Elter, A Engert and M Reiser (2004) “Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin’s lymphoma”, Haematologica. Pavia, Italy, 89(7), pp. 875-876. doi: 10.3324/%x.